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Pleuropulmonary complications after endoscopic injection sclerotherapy for treatment of
esophagogastric varices are not uncommon but are usually mild and self-limited. Herein
we report a male patient with liver cirrhosis who underwent endoscopic injection
sclerotherapy, using a mixture of n-butyl-2-cyanoacrylate and ethiodized oil for
obliteration of gastric varices. After the procedure, he developed moderate amount of
left pleural effusion that persisted for a period of time and required thoracentesis and
medical treatment. We believed that the inadvertent retrograde reflux of the embolized
glue and ethiodized oil via the portosystemic venous collateral into the left pleura might
be the possible mechanism for the development of left pleural effusion as the droplets of
ethiodized oil were seen along the left pleura on the imaging studies.
& 2006 Elsevier Ltd. All rights reserved.Introduction
Because of its efficacy and safety, endoscopic injection
sclerotherapy (EIS) has now become the treatment of choice
for obliteration of esophagogastric varices.1,2 SatisfactoryElsevier Ltd. All rights reserved.
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m (V. Boonsarngsuk).hemostasis in cases of acute variceal bleeding can be
achieved by injection of various agents including the tissue
adhesive n-butyl-2–cyanoacrylate (NBCA), ethanolamine
oleate, polidocanol, ethanol, sodium tetradecyl sulfate,
and sodium morrhuate.3 However, NBCA is now considered
the best sclerosing agent for EIS for obliteration of bleeding
gastric varices.3–6 Undiluted cyanoacrylate almost immedi-
ately polymerizes after contact with blood, resulting in
rapid coagulation and vascular occlusion. Because of the risk
of gluing of the needle in the varix, a mixture of NBCA and
ethiodized oil is used in order to delay polymerization of
NBCA and to help fluoroscopic monitoring.7,8 Nevertheless,
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mixture may increase the risk of distal glue embolization
or reflux into other systemic vessels.9–11
Pleural effusion is not an unusual complication following
EIS but is usually mild and self-limited. It may occur in
association with pulmonary artery embolization and par-
enchymal infarction after EIS.7,12 To our knowledge, how-
ever, other possible mechanism for the development of
pleural effusion after EIS has neither been proposed nor
demonstrated by the imaging studies. Herein we report a
patient who developed left pleural effusion after EIS for
obliteration of gastric varices. We believed that we were the
first to be able to demonstrate the deposition of ethiodized
oil along the left pleura in the chest radiograph and
computed tomography (CT). The mechanism responsible
for the development of left pleural effusion was also
discussed.Figure 1 Chest radiograph performed 1 week after endoscopic
injection sclerotherapy, after gastric balloon insertion for
control of upper gastrointestinal hemorrhage, demonstrating
multiple radiopaque materials in bilateral hemithoraces and at
the left upper abdominal quadrant (arrows).
Figure 2 Chest radiograph taken 3 weeks after EIS showing a
left pleural effusion. A tubular radiopacity at the right chest is
also noted (arrow).Case report
A 43-year-old man with known hepatitis B-related liver
cirrhosis and diabetes mellitus was admitted to our hospital
because of low-grade fever, dry cough and left-sided
pleuritic chest pain. Three weeks prior to admission, he
had upper gastrointestinal bleeding and went to a private
hospital. Esophageal and gastric varices were found on
endoscopic examination. EIS was then performed by an
experienced gastroenterologist for obliteration of gastric
varices, using a mixture of 0.5mL n-butyl-2-cyanoacrylate
(Histoacryl; B-Braun Sugical GmbH, Melsungen, Germany)
and 0.7mL ethiodized oil (Lipiodol; Laboratoire Guerbet,
Aulnay-Sous-Bois, France). The procedure was successfully
done without any complication. One week after the
procedure, however, he developed a new session of upper
gastrointestinal hemorrhage that was successfully con-
trolled by balloon tamponade and continuous intravenous
administration of sandostatin. Initial chest radiograph
obtained after the balloon insertion revealed multiple
radiopaque materials in both hemithoraces and at the
gastric fundus (Fig. 1). During that time, he had no fever
or respiratory symptoms.
On admission, the patient was in no distress but was
febrile with body temperature of 38.8 1C. Physical examina-
tion revealed decreased breath sound and dullness on
percussion at the left hemithorax. Other physical findings
were unremarkable. Oxygen saturation, as detected by
pulse oximeter at room air, was 95%.
Complete blood count showed a hematocrit of 32%, white
blood cell count of 9400 cells/mm3 with 78% neutrophils,
17% lymphocytes, 15% monocytes and a platelet count of
127,000 cells/mm3. Blood sugar was 441mg/dL. Serum
lactate dehydrogenase (LDH) was 422U/L (range,
100–190). Serum protein was 78 g/L and serum amylase
was 54U/L. Other blood chemistry and coagulation tests
were within normal limits.
Initial chest radiograph revealed a moderate amount of
left pleural effusion and a tiny radiopaque density overlying
the right upper hemithorax (Fig. 2). Thoracocentesis was
then performed and yielded straw-colored pleural fluid that
was composed of a white blood cell count of 2010 cells/
mm3, with 45% neutrophils, 40% lymphocytes, and 15%eosinophils. The pleural fluid had a glucose level of 394mg/
dL, LDH of 1000U/L, protein of 43 g/L, adenosine deaminase
(ADA) of 52U/L, and amylase of 19U/L. Microscopic
examination of pleural fluid was negative for gram and
acid-fast bacilli. Moreover, there was no organism growth on
pleural fluid culture. Pleural fluid cytology revealed only
inflammatory cells. Amoxicillin-clavulanate was then given
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Figure 3 Non-enhanced CT scan of the chest performed 45
days after EIS demonstrating radiopaque materials along the
left parietal pleura (arrow) with a small left pleural effusion.
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Follow-up chest radiograph performed 3 days later showed
progressive increase in the amount of the left pleural
effusion. A repeat thoracocentesis was then performed. The
pleural fluid was found to be composed of a white blood cell
count of 7700 cells/mm3, with 54% neutrophils, 34% lym-
phocytes, and 12% eosinophils. The pleural fluid had a
glucose level of 261mg/dL, LDH of 728U/L, protein of 43 g/
L, and ADA of 34U/L. No organism was found. Lung perfusion
scintigraphy was performed but showed no perfusion defect.
The patient was treated conservatively with oral rofecox-
ib and oral amoxicillin-clavulanate. One day after the
therapy, fever was ceased and respiratory symptoms were
markedly improved. He was discharged 5 days after
hospitalization despite the still persistent left pleural
effusion.
The follow-up chest radiograph obtained 45 days after EIS
showed significant decrease in the amount of the left pleural
effusion. CT of the chest was performed and revealed a
small amount of residual left pleural effusion. There were
multiple small radiopaque foreign bodies in the left pleural
cavity, likely along the left posterior costal pleura (Fig. 3).
Multiple small radiopaque foreign bodies were also seen at
the right anterosuperior chest wall, left posterior chest
wall, and left anterior abdominal wall. These radiopaque
foreign bodies were likely to represent droplets of Lipiodol.
There was no evidence of pulmonary artery embolism or
pulmonary parenchymal abnormality. The follow-up chest
radiograph obtained 2 months after EIS demonstrated
almost complete resolution of the left pleural effusion.Discussion
Acute upper gastrointestinal hemorrhage secondary to
variceal bleeding is one of the main causes of death in
patients with liver cirrhosis and portal hypertension.13–15
Various treatment modalities have been performed to
control variceal bleeding.16–19 EIS with NBCA-ethiodized
mixture has become the treatment of choice for obliteration
of esophagogastric varices with satisfactory hemostasis.1,2
The complications of this intervention are not uncommonand vary in severity. These include chest pain, odynophagia,
pyrexia, acute gastric dilation, bacteremia, aspiration,
esophageal perforation, mediastinitis, esophageal ulcers,
esophageal stricture, bacterial peritonitis, and distal glue
embolization.
Pleural effusions developed after EIS using NBCA–lipiodol
mixture have been reported and may also occur in
association with pulmonary artery embolization and par-
enchymal infarction.7,12 In the present case, there was no
evidence of pulmonary artery embolization as confirmed by
CT scan and perfusion scintigraphy of the lungs. Pleural fluid
analysis revealed exudative fluid with high eosinophilic
white blood cells. The CT images also revealed small
radiopaque densities deposited along the left lower parietal
pleura, the right anterosuperior chest wall, the left poster-
ior chest wall, and the left anterior abdominal wall. This
should be secondary to inadvertent reflux of the sclerosing
agents into other parts of the body via the extensive
network of the portosystemic venous collaterals.20–22 In the
present case, the portophrenic and splenoazygos venous
collaterals might be the possible pathway. The glue and
ethiodized oil deposited along the left pleura then induced
parietal pleural inflammation, as the glue can induce an
intense inflammatory reaction and the metabolized ethio-
dized oil, in the form of inorganic iodine and fatty acid, can
also induce eosinophilic inflammation.23–26 The risk of reflux
or systemic embolization of NBCA–ethiodized oil mixture
may also increase when the injected volume of the
embolized material is increased.10
Treatment guidelines for symptomatic pleuropulmonary
complications of glue embolization are primarily conserva-
tive, using analgesia and oxygen as required.12 Anti-
inflammatory medication may decrease tissue response to
NBCA and may be useful for pain control in the affected
patients, and so was our patient.12
In summary, we believed that this is the first case report
of eosinophilic pleural effusion developed after EIS that
appeared to be caused by the inadvertent reflux of
embolized materials into the pleura via the portosystemic
venous collaterals. Knowledge of vascular anatomy and
drainage pathways of gastroesophageal varices in patients
with portal hypertension is therefore clinically relevant as it
provides a vascular map for the procedure. Awareness of
these unusual collateral pathways should help prevent
undesirable or serious complications that may occur after
EIS.Acknowledgment
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